Belimumab improves cutaneous lupus erythematosus regardless of systemic lupus
Recent findings show that the B-cell inhibitor belimumab significantly improved cutaneous lupus erythematosus (CLE) whether or not...
top of page
it's where dermatology lives
Featured Posts
bottom of page